CCIA
Campbell & Co Investment Adviser Portfolio holdings
AUM
$1.59B
1-Year Return
6.26%
This Quarter Return
+6.43%
1 Year Return
+6.26%
3 Year Return
+31.56%
5 Year Return
+71.41%
10 Year Return
+132.34%
AUM
$1.59B
AUM Growth
+$283M
(+22%)
Cap. Flow
+$270M
Cap. Flow
% of AUM
17.02%
Top 10 Holdings %
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432
Top Buys
| 1 |
Johnson Controls International
JCI
|
+$13.6M |
| 2 |
Bank of Montreal
BMO
|
+$11.5M |
| 3 |
AerCap
AER
|
+$10.3M |
| 4 |
Netflix
NFLX
|
+$9.78M |
| 5 |
HP
HPQ
|
+$9.36M |
Top Sells
| 1 |
Labcorp
LH
|
+$8.73M |
| 2 |
Cardinal Health
CAH
|
+$8.63M |
| 3 |
Synchrony
SYF
|
+$8.42M |
| 4 |
Brown & Brown
BRO
|
+$7.55M |
| 5 |
Unilever
UL
|
+$7.37M |
Sector Composition
| 1 | Technology | 18.73% |
| 2 | Financials | 17.33% |
| 3 | Industrials | 17.07% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Healthcare | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Crane Co
CR
$10.6B
| $754K | 0.05% |
+3,973
| New | +$754K |
|
627
Lands' End
LE
$490M
| $753K | 0.05% |
70,317
+21,393
| +44% | +$229K |
|
628
Ennis
EBF
$464M
| $749K | 0.05% |
41,281
+9,534
| +30% | +$173K |
|
|
YALA
629
Yalla Group
YALA
$1.18B
| $748K | 0.05% |
+110,951
| New | +$748K |
|
630
Organon & Co
OGN
$2.64B
| $747K | 0.05% |
+77,191
| New | +$747K |
|
631
Kelly Services Class A
KELYA
$461M
| $747K | 0.05% |
63,755
+2,550
| +4% | +$29.9K |
|
|
EFXT
632
Enerflex
EFXT
$1.26B
| $745K | 0.05% |
+94,389
| New | +$745K |
|
633
Peloton Interactive
PTON
$3.21B
| $744K | 0.05% |
107,146
+53,130
| +98% | +$369K |
|
634
NewtekOne
NEWT
$304M
| $742K | 0.05% |
65,770
+23,136
| +54% | +$261K |
|
635
Ultra Clean Holdings
UCTT
$1.12B
| $740K | 0.05% |
+32,785
| New | +$740K |
|
|
DX
636
Dynex Capital
DX
$1.66B
| $736K | 0.05% |
60,238
+26,526
| +79% | +$324K |
|
637
Zevra Therapeutics
ZVRA
$456M
| $733K | 0.05% |
+83,245
| New | +$733K |
|
638
FB Financial Corp
FBK
$2.87B
| $731K | 0.05% |
16,136
-7,776
| -33% | -$352K |
|
639
National Health Investors
NHI
$3.72B
| $729K | 0.05% |
10,401
-2,270
| -18% | -$159K |
|
640
PTC Therapeutics
PTCT
$4.66B
| $727K | 0.05% |
+14,893
| New | +$727K |
|
641
Inspire Medical Systems
INSP
$2.29B
| $725K | 0.05% |
5,588
+3,836
| +219% | +$498K |
|
642
Xperi
XPER
$277M
| $724K | 0.05% |
+91,580
| New | +$724K |
|
643
ICU Medical
ICUI
$3.27B
| $724K | 0.05% |
5,477
+2,336
| +74% | +$309K |
|
644
Teradata
TDC
$1.99B
| $723K | 0.05% |
+32,426
| New | +$723K |
|
645
Korea Electric Power
KEP
$18.1B
| $723K | 0.05% |
50,740
-17,134
| -25% | -$244K |
|
646
Legend Biotech
LEGN
$6.17B
| $721K | 0.05% |
+20,325
| New | +$721K |
|
647
Viatris
VTRS
$12B
| $721K | 0.05% |
80,716
+5,368
| +7% | +$47.9K |
|
|
ITOS
648
DELISTED
iTeos Therapeutics
ITOS
| $720K | 0.05% |
+72,262
| New | +$720K |
|
649
NovoCure
NVCR
$1.37B
| $715K | 0.05% |
+40,191
| New | +$715K |
|
650
AMERISAFE
AMSF
$851M
| $712K | 0.04% |
16,284
+11,546
| +244% | +$505K |
|